MARCH, 2013 Gene-Related Patents Issued - Full patent: http://patft.uspto.gov/netahtml/PTO/srchnum.htm
CHEMISTRY: ANALYTICAL AND IMMUNOLOGICAL TESTING
Pat No Title Assignee Date Issued Country
8,399,258 Biological markers for longevity and diseases and uses thereof Albert Einstein College of Medicine of Yeshiva University 19-Mar-13 United States
8,394,612 Method for production of an L-amino acid Ajinomoto Co., Inc. 12-Mar-13 Japan
8,394,610 Method for constructing an operon containing translationally coupled genes Ajinomoto Co., Inc. 12-Mar-13 Japan
8,404,438 Probes for detection of SULT1A1 gene, reagent containing the same, and the uses thereof Arkray, Inc. 26-Mar-13 Japan
8,399,217 High density growth of T7 expression strains with auto-induction option Brookhaven Science Associates, LLC 19-Mar-13 United States
8,389,252 Yeast strain for production of four carbon alcohols Butamax(TM) Advanced Biofuels LLC 5-Mar-13 United States
8,389,238 Long-term in vivo transgene expression Copernicus Therapeutics, Inc. 5-Mar-13 United States
8,399,218 Engineered zinc finger proteins targeting 5-enolpyruvyl shikimate-3-phosphate synthase genes Dow AgroSciences, LLC 19-Mar-13 United States
8,389,258 Perhydrolase variant providing improved specific activity E. I. du Pont de Nemours and Company 5-Mar-13 United States
8,389,257 Perhydrolase variant providing improved specific activity E. I. du Pont de Nemours and Company 5-Mar-13 United States
8,389,256 Perhydrolase variant providing improved specific activity E. I. du Pont de Nemours and Company 5-Mar-13 United States
8,389,255 Perhydrolase providing improved specific activity E. I. du Pont de Nemours and Company 5-Mar-13 United States
8,389,254 Perhydrolase providing improved specific activity E. I. du Pont de Nemours and Company 5-Mar-13 United States
8,389,260 Perhydrolase variant providing improved specific activity E. I. du Pont de Nemours and Company 5-Mar-13 United States
8,389,259 Perhydrolase variant providing improved specific activity E.I. du Pont de Nemours and Company 5-Mar-13 United States
8,394,616 Perhydrolase variant providing improved specific activity E.I. du Pont de Nemours and Company 12-Mar-13 United States
8,399,234 Perhydrolase variant providing improved specific activity E.I. du Pont de Nemours and Company 19-Mar-13 United States
8,394,617 Perhydrolase variant providing improved specific activity E.I. du Pont de Nemours and Company 12-Mar-13 United States
8,399,200 Isolation of allergen-specific immunoglobulin genes from human B-cells from atopy sufferers Fraunhofer-Gesellschaft zur Forderung der angewandten Forschung e.V 19-Mar-13 Germany
8,389,264 Recombinant microorganism that expresses a secY gene with deletion of sporulation-associated genes and method of producing thereof Kao Corporation 5-Mar-13 Japan
8,399,256 Method for introducing gene into cell, and composition for use in the method Mitsubishi Gas Chemical Company, Inc. 19-Mar-13 Japan
8,389,265 Gene associated with foam formation of acetic acid bacterium, acetic acid bacterium bred by modifying the gene and method for producing vinegar using the acetic acid bacterium Mizkan Group Corporation 5-Mar-13 Japan
8,404,477 Bacillus licheniformis and method for detoxification of zearalenone National Taiwan University 26-Mar-13 Taiwan
8,389,239 Enhanced expression and stability regions Regeneron Pharmaceuticals, Inc. 5-Mar-13 United States
8,389,213 Method for concentration of gene Suntory Holdings Limited 5-Mar-13 Japan
8,394,598 Tyrosine kinome The Johns Hopkins University 12-Mar-13 United States
8,389,276 Immortalized mouse fibroblast cell lines deficient in Bax and/or Bak The Trustees of the University of Pennsylvania 5-Mar-13 United States
8,394,613 Polyhydroxyalkanoic acid copolymer and process for preparing same Tokyo Institute of Technology 12-Mar-13 Japan
8,394,628 RNA sequence-specific mediators of RNA interference University of Massachusetts 12-Mar-13 United States
8,404,472 System for producing aromatic molecules by bioconversion V. Mane Fils 26-Mar-13 France
COMBINATORIAL CHEMISTRY TECHNOLOGY
Pat No Title Assignee Date Issued Country
8,394,742 Methods, compounds and compositions with genotype selective anticancer activity The Translation Genomics Research Institute 12-Mar-13 United States
DATA PROCESSING
Pat No Title Assignee Date Issued Country
8,392,127 Methods and gene expression signature for assessing growth factor signaling pathway regulation status Merck Sharp & Dohme Corp 5-Mar-13 United States
8,396,673 Gene assaying method, gene assaying program, and gene assaying device Sony Corporation 12-Mar-13 Japan
DRUG
Pat No Title Assignee Date Issued Country
8,394,388 Mycobacterial mutants affecting host apoptosis Albert Einstein College of Medicine of Yeshiva University 12-Mar-13 United States
8,388,971 Antibodies that bind CD40 and methods of treating cancer and enhancing immune responses Amgen Fremont Inc. 5-Mar-13 United States
8,399,424 Method for controlling the amount of gene product, and agent for controlling the amount of gene product Amino Up Chemical Co., Ltd 19-Mar-13 Japan
8,389,487 siRNA-mediated gene silencing of synuclein Ann & Robert Lurie Children's Hospital of Chicago 5-Mar-13 United States
8,394,761 Methods for treating congestive heart failure Beth Israel Deaconess Medical Center 12-Mar-13 United States
8,399,426 Method for treating breast cancer using adenine nucleotide translocator 2 (ANT2) siRNA or ANT2 shRNA Bioinfra Inc. 19-Mar-13 Korea
8,398,968 Adenoviral expression vectors Canji Inc. 19-Mar-13 United States
8,394,777 Treating immunodeficiencies by intrathymic injection of nucleotide sequences Centre National de la Recherche Scientifique 12-Mar-13 France
8,404,657 Means and methods for treating or preventing brain tumors based on the nuclear receptor tailless (Tlx) DKFZ Deutsches Krebsforschungszentrum, Stiftung des Oeffentlichen Rechts 26-Mar-13 Germany
8,388,980 Yeast-based therapeutic for chronic hepatitis C infection GlobeImmune, Inc. 5-Mar-13 United States
8,389,535 L-methylfolate treatment for psychiatric or neurologic disorders Quillin; Robert L. 5-Mar-13 United States
8,404,652 DNA-binding protein YB-1-containing collagen accumulation inhibitors Sumitomo Chemical Company, Limited 26-Mar-13 United States
8,389,491 Bispecific antisense oligonucleotides that inhibit IGFBP-2 and IGFBP-5 and methods of using same The University of British Columbia 5-Mar-13 Canada
8,389,485 Encapsulated nanoparticles for nucleic acid delivery University of Massachusetts 5-Mar-13 United States
8,389,492 Lyophilized DNA formulations for enhanced expression of plasmid DNA ViroMed Co., Ltd. 5-Mar-13 Korea
FOOD OR EDIBLE MATERIAL
Pat No Title Assignee Date Issued Country
8,389,033 Modified industrial yeast strains The Australian Wine Research Institute Ltd 5-Mar-13 Australia
MULTICELLULAR LIVING ORGANISMS
Pat No Title Assignee Date Issued Country
8,389,794 Transgenic pig as a model of Alzheimer's disease Aarhus Universitet 5-Mar-13 Denmark
8,395,023 Recombinant DNA constructs and methods for controlling gene expression Monsanto Technology LLC 12-Mar-13 United States
8,399,735 Hydroxysteroid dehydrogenase gene for alteration of plant phenotype National Research Council of Canada 19-Mar-13 Canada
8,389,795 Vectors and methods for the mutagenesis of mammalian genes Omeros Corporation 5-Mar-13 United States
8,404,929 Compositions and methods for modulating expression of gene products Pioneer Hi-Bred International, Inc. 26-Mar-13 United States
8,395,021 Highly active soybean promoter from the SUBI-3 polyubiquitin gene and uses thereof The Ohio State University Research Foundation 12-Mar-13 United States
8,399,737 Functional R-gene from Solanum bulbocastanum Wageningen Universiteit 19-Mar-13 Netherlands
NATURAL RESINS OR DERIVATIVES
Pat No Title Assignee Date Issued Country
8,394,932 Survival motor neurons (SMN) gene: a gene for spinal muscular atrophy Institut National de la Sante et de la Recherche Medicale 12-Mar-13 France
8,389,681 Methods for production of proteins Life Technologies Corporation 5-Mar-13 United States
8,404,807 Mammalian tumor susceptibility genes and their uses The Board of Trustees of the Leland Stanford Junior University 26-Mar-13 United States
ORGANIC COMPOUNDS
Pat No Title Assignee Date Issued Country
8,404,862 Ligand-conjugated monomers Alnylam Pharmaceuticals, Inc. 26-Mar-13 United States
8,404,822 Probe, probe set, probe-immobilized carrier, and genetic testing method Canon Kabushiki Kaisha 26-Mar-13 Japan
8,399,654 siRNA targeting catenin, Beat-1 (CTNNB1) Dharmacon, Inc. 19-Mar-13 United States
8,394,947 Positionally modified siRNA constructs Isis Pharmaceuticals, Inc. 12-Mar-13 United States
8,404,823 Cytokine production regulator gene and use thereof Kabushiki Kaisha Yakult Honsha 26-Mar-13 Japan
8,404,824 Splice variants of human IL-23 receptor (IL-23R) mRNA and use of a .DELTA.9 isoform in predicting inflammatory bowel diseases Medical Diagnostic Laboratories, LLC 26-Mar-13 United States
8,394,936 Methods and compositions for detecting serotypes of Chlamydia trachomatis capable of causing lymphogranuloma venereum Medical Diagnostic Laboratories, LLC 12-Mar-13 United States
8,404,829 Predictive and therapeutic markers in ovarian cancer The Regents of the University of California 26-Mar-13 United States
Bookmark and Share

Login



alta vista babel fish
To traslate this page, click a flag!
flag flag flag flag flag flag flag flag

Advertisements

Miracle Ear
What will your miracle sound like?
Miracle Ear Hearing Aids
Dayal Resources, Inc.
Translations from German to English, including patents, research papers, legalese and materials for publication. Dayal Resources, Inc. is your dependable resource. Please contact [email protected]
Eden's Bounty Multi-SanTM
Colorless, odorless, biodegradable instant sanitizer is effective against both gram positive and gram-negative bacteria; kills in 30 seconds. Free of chlorine and quaternary ammonium compounds. EPA registered food contact surface sanitizer. Austin Davis Industries, Inc.
TERRA+ CLEAN Acid-Replacement Surface Cleaner
Safe, totally natural, 100% biodegradable, multi-functional cleaning product providing safety in the workplace for both humans and environmental surfaces - without compromising performance. Can be diluted up to 25:1. Austin Davis Industries, Inc.